Hong Kong-listed pharma WuXi AppTec is investing $5 million in Creacion Ventures I as it joins over a dozen limited partners (LPs) to build a $200-million life science fund to tap investment opportunities in Greater China, North America and European Union (EU).
Continue reading this premium story with a subscription to DealStreetAsia.Subscribe
Already a Subscriber? Log in
Contact us for corporate subscriptions at email@example.com